![David Holdcroft](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di David Holdcroft
Precedenti posizioni note di David Holdcroft
Società | Posizione | Inizio | Fine |
---|---|---|---|
University of Leeds | Corporate Officer/Principal | 01/01/1991 | 01/01/1996 |
Photopharmica Ltd.
![]() Photopharmica Ltd. Medical SpecialtiesHealth Technology Photopharmica Ltd. develops and discovers novel photosensitizer products. Its products pipeline includes phenothiazinium photosensitizers for use as topical therapeutic antimicrobial agents and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization. The firm's light-activated drugs kill common disease-causing microorganisms including Gram positive and negative bacteria. The company was founded in 2001 by John Lyon and is headquartered in Leeds, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
Regno Unito | 3 |
Posizioni
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Photopharmica Ltd.
![]() Photopharmica Ltd. Medical SpecialtiesHealth Technology Photopharmica Ltd. develops and discovers novel photosensitizer products. Its products pipeline includes phenothiazinium photosensitizers for use as topical therapeutic antimicrobial agents and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization. The firm's light-activated drugs kill common disease-causing microorganisms including Gram positive and negative bacteria. The company was founded in 2001 by John Lyon and is headquartered in Leeds, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- David Holdcroft
- Esperienza